Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 17, 2024New England Journal of Medicine

Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A

View Full Paper
Ask AI
Bookmark
Share

Authors

LMLynn MalecMedical College of WisconsinFPFlora PeyvandiBroad InstituteACAnthony K.C. ChanGeneral Cardiology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Malec et al. (2024) studied this question.

synapsesocial.com/papers/68e5fef1b6db643587592d3fhttps://doi.org/10.1056/nejmoa2312611
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa2023 · 26 citations
  2. 2Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study2021 · 48 citations
  3. 3Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A2023 · 205 citations
  4. 4von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends2015 · 443 citations
  5. 5Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A2016 · 235 citations